Short Summary
Minka Lighting and Wangs Alliance settled their IPR dispute over a lighting patent before the trial was instituted. The Board dismissed the petition and treated the settlement agreement as confidential.
Detailed Summary
In IPR2024-01027 concerning U.S. Patent No. 11,028,854 B2, Minka Lighting, LLC and Wangs Alliance Corporation jointly moved to terminate the inter partes review after reaching a settlement that resolved all disputes over the patent. The Patent Trial and Appeal Board, finding good cause given the early stage of the proceeding, dismissed the petition, terminated the case, and ordered the settlement agreement to be kept confidential under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c). No claim constructions or unpatentability findings were made.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Minka Lighting, LLC vs Wangs Alliance Corporation is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Amphenol CorporationvsCredo Technology Group Ltd.
Court decision.
Aylo Freesites Ltd et al.vsDISH Technologies L.L.C. et al.
The PTAB held that 17 of the 25 challenged claims of DISH’s ’680 adaptive‑bitrate streaming patent were obvious over Ogdon and Allen, while 8 claims remained patentable.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple, on behalf of Samsung, has filed an IPR petition challenging Omni MedSci’s ’533 wearable health‑monitoring patent. The petition asserts that the claims are obvious over prior‑art references Lisogurski, Carlson, and Mannheimer and requests that the Board institute the review.
Treasure Garden, Inc.vsATLeisure, LLC
ATLeisure, LLC seeks a discretionary denial of the IPR against its adjustable‑umbrella patent, arguing settled expectations, duplicate litigation, and prior art already considered by the USPTO.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple has filed an IPR petition challenging Omni MedSci’s ’533 wearable health‑monitoring patent, arguing that all asserted claims are obvious over prior‑art references Lisogurski, Carlson and Mannheimer.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.